Cargando…

Effects of propolis on warfarin efficacy

INTRODUCTION: Warfarin is commonly used to avoid thromboembolism, predominantly for cardiovascular pathologies. However, the consumption of several herbal products is not permitted during its use due to the associated interactions. Propolis is a popular phytotherapy product made by honey bees. The u...

Descripción completa

Detalles Bibliográficos
Autores principales: Akbay, Esin, Özenirler, Çiğdem, Çelemli, Ömür Gençay, Durukan, Ahmet Baris, Onur, Mehmet Ali, Sorkun, Kadriye
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5404127/
https://www.ncbi.nlm.nih.gov/pubmed/28515748
http://dx.doi.org/10.5114/kitp.2017.66929
_version_ 1783231531616043008
author Akbay, Esin
Özenirler, Çiğdem
Çelemli, Ömür Gençay
Durukan, Ahmet Baris
Onur, Mehmet Ali
Sorkun, Kadriye
author_facet Akbay, Esin
Özenirler, Çiğdem
Çelemli, Ömür Gençay
Durukan, Ahmet Baris
Onur, Mehmet Ali
Sorkun, Kadriye
author_sort Akbay, Esin
collection PubMed
description INTRODUCTION: Warfarin is commonly used to avoid thromboembolism, predominantly for cardiovascular pathologies. However, the consumption of several herbal products is not permitted during its use due to the associated interactions. Propolis is a popular phytotherapy product made by honey bees. The use of propolis has been dramatically increasing in recent times. AIM: To evaluate the possible interactions between propolis and warfarin in a mouse model with determination of the international normalized ratio (INR) values. MATERIAL AND METHODS: CD-1 mice were employed in the experimental model. The mice were warfarinized, and propolis was administered simultaneously. The INR values were obtained. All animals were sacrificed at the end of the study. RESULTS: The baseline INR value was 0.8 ±0.1. After 72 h, the INR value increased as expected. The INR value was 7.28 ±1.08 in the control group and 5.8 ±2.88 in the propolis group. At the end of the study, the INR value was 1.3 ±0.37. Propolis interacted with warfarin and caused a decrease in the INR value. CONCLUSIONS: Propolis interactions, especially with warfarin, should be kept in mind and further studied. Healthcare specialists should be aware of this possible interaction between warfarin and propolis and inform patients about it.
format Online
Article
Text
id pubmed-5404127
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Termedia Publishing House
record_format MEDLINE/PubMed
spelling pubmed-54041272017-05-17 Effects of propolis on warfarin efficacy Akbay, Esin Özenirler, Çiğdem Çelemli, Ömür Gençay Durukan, Ahmet Baris Onur, Mehmet Ali Sorkun, Kadriye Kardiochir Torakochirurgia Pol Experimental Cardiovascular and Lung Research INTRODUCTION: Warfarin is commonly used to avoid thromboembolism, predominantly for cardiovascular pathologies. However, the consumption of several herbal products is not permitted during its use due to the associated interactions. Propolis is a popular phytotherapy product made by honey bees. The use of propolis has been dramatically increasing in recent times. AIM: To evaluate the possible interactions between propolis and warfarin in a mouse model with determination of the international normalized ratio (INR) values. MATERIAL AND METHODS: CD-1 mice were employed in the experimental model. The mice were warfarinized, and propolis was administered simultaneously. The INR values were obtained. All animals were sacrificed at the end of the study. RESULTS: The baseline INR value was 0.8 ±0.1. After 72 h, the INR value increased as expected. The INR value was 7.28 ±1.08 in the control group and 5.8 ±2.88 in the propolis group. At the end of the study, the INR value was 1.3 ±0.37. Propolis interacted with warfarin and caused a decrease in the INR value. CONCLUSIONS: Propolis interactions, especially with warfarin, should be kept in mind and further studied. Healthcare specialists should be aware of this possible interaction between warfarin and propolis and inform patients about it. Termedia Publishing House 2017-03-31 2017-03 /pmc/articles/PMC5404127/ /pubmed/28515748 http://dx.doi.org/10.5114/kitp.2017.66929 Text en Copyright: © 2017 Polish Society of Cardiothoracic Surgeons (Polskie Towarzystwo KardioTorakochirurgów) and the editors of the Polish Journal of Cardio-Thoracic Surgery (Kardiochirurgia i Torakochirurgia Polska) http://creativecommons.org/licenses/by-nc-sa/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
spellingShingle Experimental Cardiovascular and Lung Research
Akbay, Esin
Özenirler, Çiğdem
Çelemli, Ömür Gençay
Durukan, Ahmet Baris
Onur, Mehmet Ali
Sorkun, Kadriye
Effects of propolis on warfarin efficacy
title Effects of propolis on warfarin efficacy
title_full Effects of propolis on warfarin efficacy
title_fullStr Effects of propolis on warfarin efficacy
title_full_unstemmed Effects of propolis on warfarin efficacy
title_short Effects of propolis on warfarin efficacy
title_sort effects of propolis on warfarin efficacy
topic Experimental Cardiovascular and Lung Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5404127/
https://www.ncbi.nlm.nih.gov/pubmed/28515748
http://dx.doi.org/10.5114/kitp.2017.66929
work_keys_str_mv AT akbayesin effectsofpropolisonwarfarinefficacy
AT ozenirlercigdem effectsofpropolisonwarfarinefficacy
AT celemliomurgencay effectsofpropolisonwarfarinefficacy
AT durukanahmetbaris effectsofpropolisonwarfarinefficacy
AT onurmehmetali effectsofpropolisonwarfarinefficacy
AT sorkunkadriye effectsofpropolisonwarfarinefficacy